Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an updated meta-analysis of randomized controlled trials - Mantovani, A; Petracca, G; Beatrice, G; Csermely, A; Lonardo, A; Targher, G (Metabolites, 2021)